ATE275379T1 - Zusammensetzungen und verfahren zur behandlung von alopezie - Google Patents

Zusammensetzungen und verfahren zur behandlung von alopezie

Info

Publication number
ATE275379T1
ATE275379T1 AT98964084T AT98964084T ATE275379T1 AT E275379 T1 ATE275379 T1 AT E275379T1 AT 98964084 T AT98964084 T AT 98964084T AT 98964084 T AT98964084 T AT 98964084T AT E275379 T1 ATE275379 T1 AT E275379T1
Authority
AT
Austria
Prior art keywords
applying
scalp
treating alopecia
compositions
methods
Prior art date
Application number
AT98964084T
Other languages
English (en)
Inventor
Morris A Mann
Original Assignee
Morris A Mann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morris A Mann filed Critical Morris A Mann
Application granted granted Critical
Publication of ATE275379T1 publication Critical patent/ATE275379T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
AT98964084T 1997-12-19 1998-12-18 Zusammensetzungen und verfahren zur behandlung von alopezie ATE275379T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/994,347 US6030948A (en) 1997-12-19 1997-12-19 Hair regeneration compositions for treatment of alopecia and methods of application related thereto
PCT/US1998/026955 WO1999032072A1 (en) 1997-12-19 1998-12-18 Compositions and methods for treatment of alopecia

Publications (1)

Publication Number Publication Date
ATE275379T1 true ATE275379T1 (de) 2004-09-15

Family

ID=25540565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964084T ATE275379T1 (de) 1997-12-19 1998-12-18 Zusammensetzungen und verfahren zur behandlung von alopezie

Country Status (12)

Country Link
US (1) US6030948A (de)
EP (1) EP1039874B1 (de)
JP (3) JP2001526200A (de)
AT (1) ATE275379T1 (de)
AU (1) AU1928199A (de)
CA (1) CA2315395C (de)
CY (1) CY1105481T1 (de)
DE (1) DE69826149T2 (de)
DK (1) DK1039874T3 (de)
ES (1) ES2232977T3 (de)
PT (1) PT1039874E (de)
WO (1) WO1999032072A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
US20070191275A1 (en) * 1998-07-30 2007-08-16 Regenerx Biopharmaceuticals, Inc. Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
ATE292473T1 (de) * 1998-07-30 2005-04-15 Us Gov Health & Human Serv Thymosin beta 4 stimuliert wundheilung
US20060100156A1 (en) * 2004-10-01 2006-05-11 Regenerx Biopharmaceuticals, Inc. Cell nucleus-entering compositions
US20080096817A1 (en) * 1998-07-30 2008-04-24 Regenerx Biopharmaceuticals, Inc. METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6558656B2 (en) * 2000-04-20 2003-05-06 Morris Mann Oral and topical compositions and methods related thereto in the treatment of acne
FR2813190A1 (fr) * 2000-08-22 2002-03-01 Oreal Utilisation d'une sapogenine pour traiter les desordres lies a une suractivite de la 5-alpha reductase
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
US20070092450A1 (en) * 2000-10-16 2007-04-26 Mallinckrodt Inc. Tissue-specific exogenous optical agents
US20040180809A1 (en) * 2000-10-16 2004-09-16 Mallinckrodt Inc. Tissue-specific exogenous optical agents
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7045550B2 (en) * 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20030049283A1 (en) * 2001-08-31 2003-03-13 Vandell Victor E. Scalp desensitizing formulation
US7348352B2 (en) * 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
TWI353849B (en) * 2002-01-25 2011-12-11 Us Gov Health & Human Serv Methods and compositions for the promotion of hair
KR20040091014A (ko) * 2002-02-07 2004-10-27 위스콘신 얼럼나이 리서어치 화운데이션 항암 요법과 병행해서 사용하기 위한 폴리아민 화합물 및조성물
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
JP2006510556A (ja) † 2002-10-30 2006-03-30 アサト　アクチェンゲゼルシャフト　アプライド　サイエンス　アンド　テクノロジー メラトニン−日用量ユニット
US7622103B1 (en) 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
FR2855753B1 (fr) * 2003-06-03 2007-09-14 Dermo Cosmologie Lab De Composition a base de diosgenine applicable par voie topique
US20050084509A1 (en) * 2003-10-20 2005-04-21 Bernstein Eric F. Use of citric acid and low concentrations of alpha-hydroxy acids for superficial skin treatment
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060009430A1 (en) * 2004-07-01 2006-01-12 Kelly Gregory J Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US8349304B1 (en) * 2005-07-28 2013-01-08 Kerri Lynn Tate Evaporative cooling composition
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same
GB0518558D0 (en) * 2005-09-12 2005-10-19 Givaudan Sa Improvements in or related to organic compounds
US20110281802A1 (en) * 2007-11-30 2011-11-17 Immudiagnostik AG Composition for treatment and prevention of hair loss and premature graying of hair
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
EP2344198B1 (de) * 2008-09-27 2020-11-04 Jina Pharmaceuticals Inc. Pharmazeutische präparate auf lipidbasis zur topischen verabreichung
US20100120871A1 (en) * 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
FR2953722B1 (fr) * 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
JP2013514261A (ja) * 2009-12-18 2013-04-25 ロレアル ケラチン繊維を処理する方法
JP5588167B2 (ja) * 2009-12-28 2014-09-10 ライオン株式会社 育毛養毛剤、毛周期変換剤および育毛養毛組成物
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
US8580742B2 (en) 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9700504B2 (en) * 2012-06-19 2017-07-11 Debraj Shome Composition and method for an intradermal hair growth solution
JP5283775B1 (ja) * 2012-09-07 2013-09-04 佐藤製薬株式会社 発毛促進剤
FR2997846B1 (fr) * 2012-11-09 2023-10-20 Oreal Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3062797B1 (de) 2014-05-23 2019-08-28 Triple Hair Inc. Zusammensetzungen zur reduzierung von haarausfall und/oder für vermehrtes erneutes haarwachstum
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
ES2902842T3 (es) 2015-07-08 2022-03-30 Triple Hair Inc Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
DE102015111123A1 (de) * 2015-07-09 2017-01-12 Andreas Schulze Kosmetische Pflege von ergrautem Haar
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US20170042859A1 (en) * 2015-08-13 2017-02-16 RiverTown Therapeutics, Inc. Compositions and methods for treating alopecia
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US9949939B2 (en) 2016-07-01 2018-04-24 Transdermal Biotechnology, Inc. Systems and methods for treating vitiligo
DE102019131415A1 (de) * 2019-11-21 2021-05-27 Lukas Karrer Kosmetische Pflege von ergrautem Haar und Wiederrückführung von ergrautem Haar zur ursprünglichen Haarfarbe
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3919044A1 (de) * 2020-06-04 2021-12-08 International Flavors & Fragrances Inc. Zusammensetzung und verfahren zur verbesserung der duftintensität mit isopropylmyristat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8307692A (pt) * 1983-03-01 1985-02-20 Rudolf Trensch Composicao de tratamento de cabelo e processo para o tratamento de cabelo
JPS62252711A (ja) * 1986-04-24 1987-11-04 Hideharu Tamaki 養毛剤
US5068315A (en) * 1990-04-12 1991-11-26 University Of Dundee Composition for the regulation of hair growth
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

Also Published As

Publication number Publication date
EP1039874A1 (de) 2000-10-04
CA2315395A1 (en) 1999-07-01
PT1039874E (pt) 2005-02-28
DK1039874T3 (da) 2005-01-24
DE69826149D1 (de) 2004-10-14
CA2315395C (en) 2008-03-18
ES2232977T3 (es) 2005-06-01
WO1999032072A1 (en) 1999-07-01
EP1039874B1 (de) 2004-09-08
DE69826149T2 (de) 2005-09-22
US6030948A (en) 2000-02-29
JP2007302705A (ja) 2007-11-22
JP2010168407A (ja) 2010-08-05
CY1105481T1 (el) 2010-04-28
AU1928199A (en) 1999-07-12
JP2001526200A (ja) 2001-12-18

Similar Documents

Publication Publication Date Title
ATE275379T1 (de) Zusammensetzungen und verfahren zur behandlung von alopezie
NO930368L (no) Sjampopreparat og suspensjonsmiddel for dette
FR2712286B1 (fr) Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
AU617116B2 (en) Scalp treatment method
DE69723476D1 (de) Mittel zur behandlung von haar
ATE209025T1 (de) Mittel zur behandlung von keratinmaterial, das zumindest ein silikongepfropftes polymer und mindestens ein höherkettiges amid enthält, sowie dessen verwendungen
LV12558A (lv) Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
DE3761286D1 (de) Haarkosmetische mittel.
BR9501652A (pt) Usos de um antagonista de substancia P em uma composição cosmética processo de tratamento cosmético composição cosmética e uso da capsaicina
DE59308920D1 (de) Verfahren zur gewinnung von apfelwachs, durch diese verfahren erhältliches apfelwachs sowie apfelwachshaltige kosmetische mittel
DE69500062D1 (de) Set, Verfahren, Mittel und Zusammensetzung zur Färbung von Keratinfasern
ATE65388T1 (de) Kosmetisches mittel.
ATE227969T1 (de) Verfahren und mittel zur dauerhaften verformung von keratinfasern
ATA904485A (de) Hautregenerierendes kosmetisches mittel und verfahren zu seiner herstellung
ATE202275T1 (de) Harnstoff enthaltende zusammensetzung und ihre kosmetische und dermatologische verwendung
DE69834047D1 (de) Verwendung einer Zubereitung und ein kosmetisches Verfahren zur Verminderung und Vorbeugung von beissender der Haut
DE3777656D1 (de) Mittel zur behandlung von alopezien.
ATE236610T1 (de) Oxidationfärbemittel für keratinfasern, das eine laccase enthält, und verfahren zur färbung mit diesem mittel
FR2545720B1 (fr) Composition cosmetique pour le traitement des cheveux et de la peau, contenant des oxathiazinones
FR2760365B1 (fr) Composition pharmaceutique ou cosmetologique contenant au moins un retinoide, et methode de traitement cosmetique des modifications liees au vieillissement de la peau et/ou des phaneres
ATE260086T1 (de) Oxidationsfärbemittel für keratinfasern, das eine laccase enthält, und verfahren zur färbung mit diesem mittel
ATA222687A (de) Färbemittel für keratinfasern und insbesondere humanhaare, sowie verfahren zum färben von keratinfasern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1039874

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee